Monday, December 22, 2014

E-Learning

Book Learning
Mycobacterium  (PDF / PPT )
Mycobacterium Tuberculosis  (PDF /PPT )
Mycobacterium leprae (PDF /PPT )
Mycobacterium avium (PDF /PPT )
WHO guidelines for the collection of human specimens for laboratory diagnosis of avian influenza infection (PDF /DOC /PPT )
CLONING  (PDF / PPT )
Gel Electrophoresis  (PDF / PPT )
Basic Learning
Protocol Learning
Agarose gel electrophoresis (basic method)  (PDF / PPT )
COSMID LIBRARY  (PDF / PPT )
DNA extraction from agarose gels (basic method) (PDF / PPT )
Recovering DNA from agarose gels  (PDF / PPT )
Restriction enzyme digestion of DNA  (PDF / PPT )
Transformation of plasmid DNA to competent E coli cells  (PDF / PPT )
CARBOHYDRATE ASSAYS  (PDF / PPT )
CELL ENVELOPE PREPARATION  (PDF / PPT )
CHROMOSOMAL DNA ISOLATION  (PDF / PPT )
CROSSLINKING OF INTACT CELLS  (PDF / PPT )
CROSSLINKING OF PROTEINS  (PDF / PPT )
DANSYL-POLYMYXIN SYNTHESIS  (PDF / PPT )
DINITROPHENYLATION ASSAY FOR POLYMYXIN B  (PDF / PPT )
DNA ISOLATION FROM AGAROSE GELS WITH DEAE PAPER  (PDF / PPT )
DOUBLE IMMUNODIFFUSION  (PDF / PPT )
ESTIMATION OF AMINO GROUPS USING TNBS  (PDF / PPT )
FUSION PROTOCOL  (PDF / PPT )
Virus Replication
Slide 1 Virus replication (ppt ; ps )
Slide 2 Role of nucleic acid-transfection (ppt ; ps )
Slide 3 Steps in Viral Replication (ppt ; ps )
Slide 4 DNA Viruses (ppt ; ps )
Slide 5 DNA replication (ppt ; ps )
Slide 6 RNA Replication (ppt ; ps )
Slide 7 Replication of Single-Stranded RNA Viruses (ppt ; ps )
Slide 8 Maturation and Release (ppt ; ps )
Slide 9 Complex Viruses (ppt ; ps )
Slide 10 Defective Interfering Particles (ppt ; ps )
Slide 11 Viroids (ppt ; ps )
Arboviruses
Slide-1 Arthropod-Borne Viruses (ppt ; ps )
Slide-2 Arthropod-Borne Viruses (ppt ; ps )
Slide-3 Transmission Cycles (ppt ; ps )
Slide-4 Man-Arthropod-Man Cycle (ppt ; ps )
Slide-5 Animal-Arthropod-Man Cycle (ppt ; ps )
Slide-6 Arthropod Vectors (ppt ; ps )
Slide-7 Examples of Arthropod Vectors (ppt ; ps )
Slide-8 Animal Reservoirs (ppt ; ps )
Slide-9 Diseases Caused (ppt ; ps )
Slide-10 Diagnosis (ppt ; ps )
Slide-11 Prevention (ppt ; ps )
Slide-12 Japanese Encephalitis (ppt ; ps )
Slide-13 Risk of Japanese Encephalitis Worlwide,1996 (ppt ; ps )
Slide-14 Yellow Fever (1) (ppt ; ps )
Slide-15 Yellow Fever (2) (ppt ; ps )
Slide-16 Global Distribution of Yellow Fever,1996 (ppt ; ps )
Slide-17 Dengue (1) (ppt ; ps )
Slide-18 Distribution of Dengue (ppt ; ps )
Slide-19 Dengue (2) (ppt ; ps )
CongenitalViral Infection
Slide-1 Congenital Viral Infections (ppt ; ps )
Slide-2 Congenital,  Perinatal, and Neonatal Viral Infections (ppt ; ps )
Slide-3 Rubella (ppt ; ps )
Slide-4 Characteristics of Rubella (ppt ; ps )
Slide-5 Clinical Features (ppt ; ps )
Slide-6 Rash of Rubella (ppt ; ps )
Slide-7 Risks of rubella infection during pregnancy (ppt ; ps )
Slide-8 Congenital Rubella Syndrome (ppt ; ps )
Slide-9 Outcome  (ppt ; ps )
Slide-10 Prevention (1) (ppt ; ps )
Slide-11 Prevention (2) (ppt ; ps )
Slide-12 Laboratory Diagnosis (ppt ; ps )
Slide-13 Typical Serological Events following acute rubella infection (ppt ; ps )
Slide-14 Cytomegalovirus (ppt ; ps )
Slide-15 Congenital Infection (ppt ; ps )
Slide-16 Cytomegalic Inclusion Disease (ppt ; ps )
Slide-17 Incidence of Cytomegalic Disease (ppt ; ps )
Slide-18 Diagnosis (ppt ; ps )
Slide-19 Management (ppt ; ps )
Slide-20 Neonatal Herpes Simplex (1) (ppt ; ps )
Slide-21 Neonatal Herpes Simplex (2) (ppt ; ps )
Slide-22 Parvovirus (ppt ; ps )
Slide-23 Congenital Parvovirus Infection (ppt ; ps )
Slide-24 Varicella-Zoster Virus (ppt ; ps )
Slide-25 Neonatal Varicella (ppt ; ps )
Diarrhoea
Slide-1 Diarrhoeal Viruses (ppt ; ps )
Slide-2 Viral Gastroenteritis (ppt ; ps )
Slide-3 Viruses found in the gut (1)  (ppt ; ps )
Slide-4 Viruses found in the gut (2)  (ppt ; ps )
Slide-5 Rotavirus Particle  (ppt ; ps )
Slide-6 Rotaviruses (1)  (ppt ; ps )
Slide-7 Rotaviruses (2)  (ppt ; ps )
Slide-8 Adenovirus Particle (ppt ; ps )
Slide-9 Enteric Adenoviruses  (ppt ; ps )
Slide-10 Astrovirus Particles (ppt ; ps )
Slide-11 Astroviruses  (ppt ; ps )
Slide-12 Calicivirus Particles  (ppt ; ps )
Slide-13 Caliciviruses  (ppt ; ps )
Slide-14 Norwalk-like Virus Particles  (ppt ; ps )
Slide-15 Norwalk-like Viruses  (ppt ; ps )
Slide-16 Other Possible Diarrhoeal Viruses (ppt ; ps )
Enteroviruses
Slide-1 Enteroviruses (ppt ; ps )
Slide-2 Enteroviruses  (ppt ; ps )
Slide-3 Enterovirus Particles (ppt ; ps )
Slide-4 History (ppt ; ps )
Slide-5 Properties of Enteroviruses (ppt ; ps )
Slide-6 Poliovirus (ppt ; ps )
Slide-7 Pathogenesis (ppt ; ps )
Slide-8 Clinical Manifestations (ppt ; ps )
Slide-9 Laboratory Diagnosis (ppt ; ps )
Slide-10 Prevention (1) (ppt ; ps )
Slide-11 Prevention (2) (ppt ; ps )
Slide-12 Current Status of Wild Poliovirus Transmission (ppt ; ps )
Slide-13 Coxsackieviruses (ppt ; ps )
Slide-14 Echoviruses (ppt ; ps )
Slide-15 New Enteroviruses (ppt ; ps )
Slide-16 Diseases associated with Enteroviruses (ppt ; ps )
Slide-17 Disease Associations (1) (ppt ; ps )
Slide-18 Disease Associations (2) (ppt ; ps )
Slide-19 Laboratory Diagnosis (ppt ; ps )
Slide-20 Cytopathic Effect (ppt ; ps )
Slide-21 Management and Prevention (ppt ; ps )
Hepatitis
Slide-1 Hepatitis A-E Viruses (ppt ; ps )
Slide-2 Viral Hepatitis - Historical Perspectives (ppt ; ps )
Slide-3 Type of Hepatitis  (ppt ; ps )
Slide-4 Hepatitis A Virus (ppt ; ps )
Slide-5 Hepatitis A Virus (ppt ; ps )
Slide-6 Hepatitis A - Clinical Features (ppt ; ps )
Slide-7 Hepatitis A Infection (ppt ; ps )
Slide-8 Hepatitis A Virus Transmission (ppt ; ps )
Slide-9 Global Patterns of Hepatitis A Virus Transmission  (ppt ; ps )
Slide-10 Geographic Distribution of HAV Infection (ppt ; ps )
Slide-11 Laboratory Diagnosis (ppt ; ps )
Slide-12 Hepatitis A Vaccination Strategies (ppt ; ps )
Slide-13 Hepatitis A Prevention - Immune Globulin (ppt ; ps )
Slide-14 Hepatitis B Virus (ppt ; ps )
Slide-15 Hepatitis B Virus - Virology (ppt ; ps )
Slide-16 Hepatitis B - Clinical Features (ppt ; ps )
Slide-17 Spectrum of Chronic Hepatitis B Diseases (ppt ; ps )
Slide-18 Acute Hepatitis B Virus Infection with Recovery (ppt ; ps )
Slide-19 Progression to Chronic Hepatitis B Virus Infection  (ppt ; ps )
Slide-20 Outcome of Hepatitis B Virus Infection (ppt ; ps )
Slide-21 Global Patterns of Chronic HBV Infection (ppt ; ps )
Slide-22 Geographic Distribution of Chronic HBV Infection (ppt ; ps )
Slide-23 Concentration of Hepatitis B Virus in Various Body Fluids (ppt ; ps )
Slide-24 Hepatitis B Virus (ppt ; ps )
Slide-25 Diagnosis (ppt ; ps )
Slide-26 Treatment (ppt ; ps )
Slide-27 Prevention (ppt ; ps )
Slide-28 Hepatitis C Virus (ppt ; ps )
Slide-29 Hepatitis C Virus (ppt ; ps )
Slide-30 Terminology (ppt ; ps )
Slide-31 Hepatitis C - Clinical Features (ppt ; ps )
Slide-32 Chronic Hepatitis C Infection (ppt ; ps )
Slide-33 Hepatitis C Virus Infection (ppt ; ps )
Slide-34 Risk Factors Associated with Transmission of HCV (ppt ; ps )
Slide-35 Prevalance of HCV Infection Among Blood Donors (ppt ; ps )
Slide-36 Laboratory Diagnosis (ppt ; ps )
Slide-37 Prognostic Tests (ppt ; ps )
Slide-38 Treatment (ppt ; ps )
Slide-39 Prevention of Hepatitis C (ppt ; ps )
Slide-40 Hepatitis D (Delta) Virus (ppt ; ps )
Slide-41 Hepatitis D Virus (ppt ; ps )
Slide-42 Hepatitis D - Clinical Features (ppt ; ps )
Slide-43 Hepatitis D Virus Modes of Transmission (ppt ; ps )
Slide-44 HBV - HDV Coinfection (ppt ; ps )
Slide-45 HBV - HDV Coinfection (ppt ; ps )
Slide-46 HBV - HDV Superinfection (ppt ; ps )
Slide-47 Geographic Distribution of HDV Infection (ppt ; ps )
Slide-48 Hepatitis D - Prevention (ppt ; ps )
Slide-49 Hepatitis E Virus (ppt ; ps )
Slide-50 Hepatitis E Virus (ppt ; ps )
Slide-51 Hepatitis E - Clinical Features (ppt ; ps )
Slide-52 Hepatitis E Virus Infection (ppt ; ps )
Slide-53 Hepatitis E-Epidemiologic Features (ppt ; ps )
Slide-54 Geographic Distribution of Hepatitis E (ppt ; ps )
Slide-55 Prevention and Control Measures for Travelers to HEV-Endemic Regions (ppt ; ps )
Herpes
Slide-1 Herpesvirus Infections in Immunocompromised Patients (ppt ; ps )
Slide-2 Immunocompromising conditions  (ppt ; ps )
Slide-3 Herpesvirus (ppt ; ps )
Slide-4 Herpesvirus Particle (ppt ; ps )
Slide-5 Herpes Simplex Virus (ppt ; ps )
Slide-6 Herpes Simplex Virus (ppt ; ps )
Slide-7 Varicella-Zoster Virus (ppt ; ps )
Slide-8 Immunocompromised individuals (ppt ; ps )
Slide-9 Treatment and Prevention  (ppt ; ps )
Slide-10 Cytomegalovirus (ppt ; ps )
Slide-11 Immunocompromised individuals (ppt ; ps )
Slide-12 Clinical Manifestations (ppt ; ps )
Slide-13 AIDS Patients (ppt ; ps )
Slide-14 Solid organ transplant recipients e.g. renal, liver, heart (ppt ; ps )
Slide-15 Bone marrow transplant recipient (ppt ; ps )
Slide-16 Laboratory Diagnosis (1) (ppt ; ps )
Slide-17 Cytopathic Effect of CMV (ppt ; ps )
Slide-18 DEAFF test for CMV (ppt ; ps )
Slide-19 Laboratory Diagnosis (2) (ppt ; ps )
Slide-20 CMV pp65 antigenaemia test (ppt ; ps )
Slide-21 Management (1) (ppt ; ps )
Slide-22 Management (2) (ppt ; ps )
Slide-23 Prevention (ppt ; ps )
Slide-24 Post-transplant surveillance (ppt ; ps )
Slide-25 Epstein-Barr Virus (ppt ; ps )
Slide-26 Risk Groups (ppt ; ps )
Slide-27 Post Transplant Lymphoproliferative Disorder (ppt ; ps )
Slide-28 HHV-6 and HHV-7 (ppt ; ps )
Slide-29 Human Herpes Virus 8 (ppt ; ps )
Herpes Viruses
Slide-1 Herpesviruses (ppt ; ps )
Slide-2 Properties of herpesviruses  (ppt ; ps )
Slide-3 Herpesvirus Particle  (ppt ; ps )
Slide-4 Herpes Simplex Viruses  (ppt ; ps )
Slide-5 Properties  (ppt ; ps )
Slide-6 Epidemiology (1)  (ppt ; ps )
Slide-7 Epidemiology (2)  (ppt ; ps )
Slide-8 Pathogenesis (ppt ; ps )
Slide-9 Clinical Manifestations (ppt ; ps )
Slide-10 Oral-facial Herpes (ppt ; ps )
Slide-11 Gingivostomatitis (ppt ; ps )
Slide-12 Ocular Herpes (ppt ; ps )
Slide-13 Genital Herpes (ppt ; ps )
Slide-14 Herpes Simplex Encephalitis (ppt ; ps )
Slide-15 Neonatal Herpes Simplex (1) (ppt ; ps )
Slide-16 Neonatal Herpes Simplex (2) (ppt ; ps )
Slide-17 Other Manifestations (ppt ; ps )
Slide-18 Laboratory Diagnosis (ppt ; ps )
Slide-19 Fig-3 HSV-Infected (ppt ; ps )
Slide-20 Management (ppt ; ps )
Slide-21 Varicella- Zoster Virus (ppt ; ps )
Slide-22 Properties (ppt ; ps )
Slide-23 Epidemiology (ppt ; ps )
Slide-24 Pathogenesis (ppt ; ps )
Slide-25 Varicella (ppt ; ps )
Slide-26 Rash of Chickenpox (ppt ; ps )
Slide-27 Herpes Zoster (Shingles) (ppt ; ps )
Slide-28 Shingles (ppt ; ps )
Slide-29 Congenital VZV Infection (ppt ; ps )
Slide-30 Neonatal Varicella (ppt ; ps )
Slide-31 Laboratory Diagnosis (ppt ; ps )
Slide-32 Cytopathic Effect of VZV (ppt ; ps )
Slide-33 Management (ppt ; ps )
Slide-34 Prevention (ppt ; ps )
Slide-35 Cytomegalovirus (ppt ; ps )
Slide-36 Properties (ppt ; ps )
Slide-37 Epidemiology (ppt ; ps )
Slide-38 Pathogenesis (ppt ; ps )
Slide-39 Clinical Manifestations (ppt ; ps )
Slide-40 Congenital Infection (ppt ; ps )
Slide-41 Cytomegalic Inclusion Disease (ppt ; ps )
Slide-42 Incidence of Cytomegalic Disease (ppt ; ps )
Slide-43 Laboratory Diagnosis (1) (ppt ; ps )
Slide-44 CMV pp65 antigenaemia test (ppt ; ps )
Slide-45 Laboratory Diagnosis (2) (ppt ; ps )
Slide-46 Cytopathic Effect of CMV (ppt ; ps )
Slide-47 DEAFF test for CMV (ppt ; ps )
Slide-48 Specimens for Laboratory Diagnosis (ppt ; ps )
Slide-49 Treatment (ppt ; ps )
Slide-50 Prevention (ppt ; ps )
Slide-51 Epstein-Barr Virus (ppt ; ps )
Slide-52 Epstein-Barr Virus (EBV) (ppt ; ps )
Slide-53 Epidemiology (ppt ; ps )
Slide-54 Pathogenesis (ppt ; ps )
Slide-55 Disease Association (ppt ; ps )
Slide-56 Infectious Mononuclosis (ppt ; ps )
Slide-57 Burkitt’s Lymphoma (1) (ppt ; ps )
Slide-58 Burkitt’s Lymphoma (2) (ppt ; ps )
Slide-59 Nasopharyngeal Carcinoma (ppt ; ps )
Slide-60 Immunocompromised Patients (ppt ; ps )
Slide-61 Diagnosis (ppt ; ps )
Slide-62 Vaccination (ppt ; ps )
Slide-63 Other Human Herpes Viruses (ppt ; ps )
Slide-64 Properties of HHV-6 and 7 (ppt ; ps )
Slide-65 Epidemiology and Pathogenesis (ppt ; ps )
Slide-66 Clinical Manifestations (1) (ppt ; ps )
Slide-67 Clinical Manifestations (2) (ppt ; ps )
Slide-68 Roseala Infantum (ppt ; ps )
Slide-69 Diagnosis and Management (ppt ; ps )
Slide-70 Human Herpes Virus 8 (ppt ; ps )
Slide-71 Kaposi’s Sarcoma (ppt ; ps )
HIV
Slide-1 Human Immunodeficiency Virus (ppt ; ps )
Slide-2 Human Immunodeficiency Virus  (ppt ; ps )
Slide-3 HIV particles (ppt ; ps )
Slide-4 HIV Genome (ppt ; ps )
Slide-5 Replication (ppt ; ps )
Slide-6 HIV-1 Genotypes (ppt ; ps )
Slide-7 Fig-1 (ppt ; ps )
Slide-8 Fig-2 (ppt ; ps )
Slide-9 Schematic of HIV Replication (ppt ; ps )
Slide-10 Clinical Features (ppt ; ps )
Slide-11 Opportunistic Infections (ppt ; ps )
Slide-12 Opportunistic Tumours (ppt ; ps )
Slide-13 Kaposi’s Sarcoma (ppt ; ps )
Slide-14 Other Manifestations (ppt ; ps )
Slide-15 Epidemiology (ppt ; ps )
Slide-16 Adults and Children Estimated (ppt ; ps )
Slide-17 HIV Pathogenesis (ppt ; ps )
Slide-18 HIV half-lives (ppt ; ps )
Slide-19 HIV-I Half Life (ppt ; ps )
Slide-20 Laboratory Diagnosis (ppt ; ps )
Slide-21 ELISA for HIV antibody (ppt ; ps )
Slide-22 Western blot for HIV antibody (ppt ; ps )
Slide-23 Other diagnostic assays (ppt ; ps )
Slide-24 Prognostic tests (ppt ; ps )
Slide-25 Anti-Retorvirual Susceptibility Testing (ppt ; ps )
Slide-26 Fig-3 (ppt ; ps )
Slide-27 Treatment (ppt ; ps )
Slide-28 Anti-Retroviral Agents (ppt ; ps )
Slide-29 Prevention  (ppt ; ps )
Quality Control
Slide-1 Laboratory Quality Control (ppt ; ps )
Slide-2 Definitions (1) (ppt ; ps )
Slide-3 Definitions (2) (ppt ; ps )
Slide-4 Variables that affect the quality of results  (ppt ; ps )
Slide-5 Errors in measurement (ppt ; ps )
Slide-6 Sources of error (ppt ; ps )
Slide-7 Random Error (ppt ; ps )
Slide-8 Random Errors (ppt ; ps )
Slide-9 Systematic Error (ppt ; ps )
Slide-10 Systematic Errors (ppt ; ps )
Slide-11 Internal Quality Control Program for Serological Testing (ppt ; ps )
Slide-12 Shewhart Control Charts (ppt ; ps )
Slide-13 Westgard rules (ppt ; ps )
Slide-14 Shewhart Chart (ppt ; ps )
Slide-15 Warning rules (ppt ; ps )
Slide-16 Mandatory rules (ppt ; ps )
Slide-17 Westgard Rules 1 3SD (ppt ; ps )
Slide-18 Westgard Rules 10X (ppt ; ps )
Slide-19 Follow-up action in the event of a violatio (ppt ; ps )
Virological Test
Slide-1 Virological Tests (ppt ; ps )
Slide-2 Diagnostic Methods in Virology (ppt ; ps )
Slide-3 Direct Examination (ppt ; ps )
Slide-4 Indirect Examination (ppt ; ps )
Slide-5 Serology (ppt ; ps )
Slide-6 Virus Isolation (ppt ; ps )
Slide-7 Cell Cultures (ppt ; ps )
Slide-8 Cytopathic Effect (1) (ppt ; ps )
Slide-9 Cytopathic Effect (2) (ppt ; ps )
Slide-10 Haemadsorption (ppt ; ps )
Slide-11 Problems with cell culture (ppt ; ps )
Slide-12 Rapid Culture Techniques (ppt ; ps )
Slide-13 DEAFF test for CMV (ppt ; ps )
Slide-14 Viruses Isolated by Cell Culture (ppt ; ps )
Slide-15 Electron Microscopy (ppt ; ps )
Slide-16 Electronmicrographs (ppt ; ps )
Slide-17 Immune Electron Microscopy (ppt ; ps )
Slide-18 Problems with Electron Microscopy (ppt ; ps )
Slide-19 Serology (ppt ; ps )
Slide-20 Typical Serological Profile After Acute Infection (ppt ; ps )
Slide-21 Complement Fixation Test (ppt ; ps )
Slide-22 ELISA for HIV antibody (ppt ; ps )
Slide-23 Western Blot (ppt ; ps )
Slide-24 Usefulness of Serological Results (ppt ; ps )
Slide-25 Problems with Serology (ppt ; ps )
Slide-26 CSF antibodies (ppt ; ps )
Slide-27 Rapid Diagnosis Based on the Detection of Viral Antigens (ppt ; ps )
Slide-28 Immunofluorescense (ppt ; ps )
Slide-29 CMV pp65 antigenaemia test (ppt ; ps )
Slide-30 Advantages and Disadvantages (ppt ; ps )
Slide-31 Specimens for Routine Tests (ppt ; ps )
Slide-32 Molecular Methods (ppt ; ps )
Slide-33 Classical Molecular Techniques (ppt ; ps )
Slide-34 Polymerase Chain Reaction (1) (ppt ; ps )
Slide-35 Polymerase Chain Reaction (2) (ppt ; ps )
Slide-36 Schematic of PCR (ppt ; ps )
Slide-37 Other Newer Molecular Techniques (ppt ; ps )
Slide-38 Comparison between PCR and other nucleic acid Amplification Technique (ppt ; ps )
Virus Replication
Slide 1 Virus replication (ppt ; ps )
Slide 2 Role of nucleic acid-transfection (ppt ; ps )
Slide 3 Steps in Viral Replication (ppt ; ps )
Slide 4 DNA Viruses (ppt ; ps )
Slide 5 DNA replication (ppt ; ps )
Slide 6 RNA Replication (ppt ; ps )
Slide 7 Replication of Single-Stranded RNA Viruses (ppt ; ps )
Slide 8 Maturation and Release (ppt ; ps )
Slide 9 Complex Viruses (ppt ; ps )
Slide 10 Defective Interfering Particles (ppt ; ps )
Slide 11 Viroids  (ppt ; ps )
Zoonosis
Slide-1 Viral Zoonosis (ppt ; ps )
Slide-2 Definition (ppt ; ps )
Slide-3 Rabies Virus (ppt ; ps )
Slide-4 Rabies Virus (ppt ; ps )
Slide-5 Epidemiology (ppt ; ps )
Slide-6 Pathogenesis (ppt ; ps )
Slide-7 Laboratory Diagnosis (ppt ; ps )
Slide-8 Diagnosis of Rabies (ppt ; ps )
Slide-9 Management and Prevention (ppt ; ps )
Slide-10 Postexposure Prophylaxis (ppt ; ps )
Slide-11 Rabies Vaccines (ppt ; ps )
Slide-12 Control of Rabies (ppt ; ps )
Slide-13 Arenaviruses (ppt ; ps )
Slide-14 Lassa Fever (ppt ; ps )
Slide-15 Clinical Manifestations (ppt ; ps )
Slide-16 Laboratory Diagnosis (ppt ; ps )
Slide-17 Management and Prevention (ppt ; ps )
Slide-18 Junin and Macupo Viruses (ppt ; ps )
Slide-19 Hantaviruses (ppt ; ps )
Slide-20 History (ppt ; ps )
Slide-21 Some Subtypes of hantaviruses associated with human disease (ppt ; ps )
Slide-22 Rodent Carriers of Hantaviruses (ppt ; ps )
Slide-23 Clinical Features of Hantavirus Disease (ppt ; ps )
Slide-24 Comparative Clinical Features of Recognized Hantavirus Disease (HVD) (ppt ; ps )
Slide-25 Hantavirus Pulmonary Syndrome (HPS) (ppt ; ps )
Slide-26 Diagnosis (ppt ; ps )
Slide-27 Treatment and Prevention (ppt ; ps )

* For Student & Researcher only
total view : 8237 times